Observational Study of the Sleuth Implantable ECG Monitoring System
Status unconfirmed
Conditions studied: Syncope, Presyncope, Fainting, Cardiac Arrhythmia
In brief
The purpose of this study is to obtain information on real-world device performance clinical assessments and clinical outcomes of patients receiving the Sleuth Implantable ECG Monitoring System.
Key facts
- Study ID
- NCT00717106
- Run by
- Transoma Medical
- People needed
- 250
- Starts
- 2008-07-01
- Last updated by the study team
- 2009-05-05
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with clinical syndromes or situations at increased risk of cardiac arrhythmias
- Patients who experience transient symptoms that may suggest a cardiac arrhythmia
You may not qualify if…
- Patients that have had a myocardial infarction (MI) < 30 days prior to implant
Where it is running
- Piedmont Hospital — Atlanta, Georgia, United States
- Western Maryland Health Systems — Cumberland, Maryland, United States
- Cardiology Consultants of East Michigan — Lapeer, Michigan, United States
- St. Luke's - Roosevelt — New York, New York, United States
- SUMMA-NEOCS Health Systems — Akron, Ohio, United States
- Main Line Health - Lankenau Hospital — Wynnewood, Pennsylvania, United States
- Center for Cardiac Arrhythmias — Houston, Texas, United States
- Morgantown Internal Medicine Group — Morgantown, West Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.